Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma

Izak Faiena,1,2 Amy L Cummings,3 Anna M Crosetti,3 Allan J Pantuck,1,2 Karim Chamie,1,2 Alexandra Drakaki1–3 1Department of Urology, 2Institute of Urologic Oncology, 3Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine at University of California, L...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Faiena I (Awdur), Cummings AL (Awdur), Crosetti AM (Awdur), Pantuck AJ (Awdur), Chamie K (Awdur), Drakaki A (Awdur)
Fformat: Llyfr
Cyhoeddwyd: Dove Medical Press, 2018-01-01T00:00:00Z.
Pynciau:
Mynediad Ar-lein:Connect to this object online.
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Rhyngrwyd

Connect to this object online.

3rd Floor Main Library

Manylion daliadau o 3rd Floor Main Library
Rhif Galw: A1234.567
Copi 1 Ar gael